Henry Ames
VP Corporate Strategy ZoomlogiHenry Ames, Vice President Corporate Strategy - ZoomLogi
Henry Ames serves as the Vice President of Corporate Strategy for ZoomLogi an AI-native platform for healthcare and life sciences logistics. In his current role, Henry supports business development, strategic marketing, product development, and voice-of-customer.
He brings 25+ years in life sciences supply chain leadership. Previously, he was General Manager of Logistics Orchestration at TraceLink, Director of Global Life Sciences at Everstream Analytics, and spent 18+ years at Sensitech, culminating as General Manager of its life sciences vertical. Earlier, he was a principal at Megunticook Management, a $150M Boston-based VC firm investing in communications, media, and technology.
Henry co-chairs the Parenteral Drug Association's (PDA) Supply Chain Management Interest Group (SCMIG) and contributes to International Air Transport Association's (IATA) Cell and Gene Therapy Focus Unit and Healthcare Cargo Working Group (HCWG). Henry also serves on the Advisory Board of Healthcare Chain Institute (HCI).
He holds an MBA from Babson's F.W. Olin Graduate School of Business and a double major in Business Management and Entrepreneurship from Florida State University. Henry also serves as President and Director of the Easton Community Corporation, a 501(c)(2) supporting non-profits in North Easton, MA
Operationalizing Innovation: Delivering Future-Ready, Responsible, and High-Performing Supply Chains
1:50 PM Track B: From SOP to Audit-Ready: AI-Enabled Exception Management Across the Pharma Supply Chain
Pharma supply chain teams rarely lack SOPs; what they lack are the tools to execute those SOPs at speed and scale. This panel brings together two perspectives from opposite ends of the specialty pharma lifecycle: a preclinical-stage biotech advancing engineered T cell (CAR-T) therapies, and a commercial-stage cell and gene therapy manufacturer focused on scaling patient access. Together, they will examine how AI voice and text agents are closing the gap between documented SOPs and what actually happens when an exception, such as a cold chain excursion or a delayed clinical shipment, occurs in the field.
- How exception handling differs between preclinical trial logistics and higher-volume, patient-facing commercial distribution
- How to move from exception detection to documented, audit-ready resolution in minutes rather than days
- How to digitize SOP and Quality Agreement workflows, without a heavy IT lift, in a way Quality teams can trust and audit
Check out the incredible speaker line-up to see who will be joining Henry.
Download The Latest Agenda